Is Medtronic plc (MDT) a Buy, Sell, or Hold?
Medtronic plc
NYSE:MDT
$80.47 USD
$1.17 (1.47%)
- Volume
- 7.11M
- Average Volume
- 10.33M
- Market Capitalization
- $103.01B
- P/E Ratio
- 21.46
- Dividend Yield
- 3.54%
- Price Target
- $91.00
- Year High
- $106.33
- Year Low
- $73.31
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.76
- Current Ratio
- $2.13
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
21
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
47
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 362.07K
MDT Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
MDT Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Walter Matthew R. | officer: SVP, Chief HR Officer | 2026-07-08 | S-Sale | 83.15 | 2026-07-09 |
| Thompson Kweli | officer: EVP & President, Neuroscience | 2026-06-18 | 0 | 2026-06-26 | |
| Thompson Kweli | officer: EVP & President, Neuroscience | 2026-06-18 | 0 | 2026-06-26 | |
| Thompson Kweli | officer: EVP & President, Neuroscience | 2026-06-18 | 0 | 2026-06-26 | |
| Thompson Kweli | officer: EVP & President, Neuroscience | 2017-08-01 | 88.06 | 2026-06-26 | |
| Thompson Kweli | officer: EVP & President, Neuroscience | 2018-01-30 | 74.67 | 2026-06-26 | |
| Thompson Kweli | officer: EVP & President, Neuroscience | 2018-07-31 | 83.97 | 2026-06-26 | |
| Thompson Kweli | officer: EVP & President, Neuroscience | 2019-07-30 | 89.08 | 2026-06-26 | |
| Thompson Kweli | officer: EVP & President, Neuroscience | 2020-07-29 | 103.26 | 2026-06-26 | |
| Thompson Kweli | officer: EVP & President, Neuroscience | 2021-08-03 | 97.33 | 2026-06-26 | |
| Thompson Kweli | officer: EVP & President, Neuroscience | 2022-08-02 | 131.26 | 2026-06-26 | |
| Thompson Kweli | officer: EVP & President, Neuroscience | 2023-08-01 | 93.08 | 2026-06-26 | |
| Thompson Kweli | officer: EVP & President, Neuroscience | 2024-07-31 | 87.76 | 2026-06-26 | |
| Thompson Kweli | officer: EVP & President, Neuroscience | 2025-07-29 | 80 | 2026-06-26 | |
| Thompson Kweli | officer: EVP & President, Neuroscience | 2026-07-28 | 91.97 | 2026-06-26 | |
| KIIL HARRY SKIP | officer: EVP & President Cardiovascular | 2026-06-08 | S-Sale | 80.44 | 2026-06-09 |
| KIIL HARRY SKIP | officer: EVP & President Cardiovascular | 2026-06-08 | S-Sale | 80.45 | 2026-06-09 |
| KIIL HARRY SKIP | officer: EVP & President Cardiovascular | 2026-06-04 | F-InKind | 83.32 | 2026-06-08 |
| Martha Geoffrey | director, officer: Chairman and CEO | 2026-06-04 | F-InKind | 83.32 | 2026-06-08 |
| Marinaro Michael | officer: EVP, Pres MedSurg and Americas | 2026-06-04 | F-InKind | 83.32 | 2026-06-08 |
| Walter Matthew R. | officer: SVP, Chief HR Officer | 2026-06-04 | F-InKind | 83.32 | 2026-06-08 |
| Blomquist Denise L. | officer: Chief Accounting Officer | 2026-06-05 | F-InKind | 83.32 | 2026-06-08 |
| Walter Matthew R. | officer: SVP, Chief HR Officer | 2026-05-26 | M-Exempt | 0 | 2026-05-28 |
| Walter Matthew R. | officer: SVP, Chief HR Officer | 2026-05-26 | M-Exempt | 0 | 2026-05-28 |
| Wall Brett A. | officer: EVP & Pres Neuroscience | 2026-05-26 | M-Exempt | 0 | 2026-05-28 |
| Wall Brett A. | officer: EVP & Pres Neuroscience | 2026-05-26 | M-Exempt | 0 | 2026-05-28 |
| Martha Geoffrey | director, officer: Chairman and CEO | 2026-05-26 | M-Exempt | 0 | 2026-05-28 |
| Martha Geoffrey | director, officer: Chairman and CEO | 2026-05-26 | M-Exempt | 0 | 2026-05-28 |
| Marinaro Michael | officer: EVP, Pres MedSurg and Americas | 2026-05-26 | M-Exempt | 0 | 2026-05-28 |
| Marinaro Michael | officer: EVP, Pres MedSurg and Americas | 2026-05-26 | M-Exempt | 0 | 2026-05-28 |
| KIIL HARRY SKIP | officer: EVP & President Cardiovascular | 2026-05-26 | M-Exempt | 0 | 2026-05-28 |
| KIIL HARRY SKIP | officer: EVP & President Cardiovascular | 2026-05-26 | M-Exempt | 0 | 2026-05-28 |
| Blomquist Denise L. | officer: Chief Accounting Officer | 2026-05-26 | M-Exempt | 0 | 2026-05-28 |
| Blomquist Denise L. | officer: Chief Accounting Officer | 2026-05-26 | M-Exempt | 0 | 2026-05-28 |
| Walter Matthew R. | officer: SVP, Chief HR Officer | 2026-05-01 | F-InKind | 80 | 2026-05-04 |
| Blomquist Denise L. | officer: Chief Accounting Officer | 2026-04-27 | A-Award | 0 | 2026-04-29 |
| Blomquist Denise L. | officer: Chief Accounting Officer | 2026-04-28 | F-InKind | 81.9 | 2026-04-29 |
| Powell Kendall J | director | 2026-04-27 | A-Award | 0 | 2026-04-29 |
| Powell Kendall J | director | 2026-04-28 | F-InKind | 81.9 | 2026-04-29 |
| NABEL ELIZABETH G | director | 2026-04-27 | A-Award | 0 | 2026-04-29 |
| NABEL ELIZABETH G | director | 2026-04-28 | F-InKind | 81.9 | 2026-04-29 |
| Lofton Kevin E | director | 2026-04-27 | A-Award | 0 | 2026-04-29 |
| Lofton Kevin E | director | 2026-04-28 | F-InKind | 81.9 | 2026-04-29 |
| Lewis Gregory P | director | 2026-04-27 | A-Award | 0 | 2026-04-29 |
| Lewis Gregory P | director | 2026-04-28 | F-InKind | 81.9 | 2026-04-29 |
| Lee Joon Sup | director | 2026-04-27 | A-Award | 0 | 2026-04-29 |
| Jellison William R | director | 2026-04-27 | A-Award | 0 | 2026-04-29 |
| HOGAN RANDALL J | director | 2026-04-27 | A-Award | 0 | 2026-04-29 |
| HOGAN RANDALL J | director | 2026-04-28 | F-InKind | 81.9 | 2026-04-29 |
| Groetelaars John P | director | 2026-04-27 | A-Award | 0 | 2026-04-29 |
| Fonseca Lidia | director | 2026-04-27 | A-Award | 0 | 2026-04-29 |
| Fonseca Lidia | director | 2026-04-28 | F-InKind | 81.9 | 2026-04-29 |
| DONNELLY SCOTT C | director | 2026-04-27 | A-Award | 0 | 2026-04-29 |
| DONNELLY SCOTT C | director | 2026-04-28 | F-InKind | 81.9 | 2026-04-29 |
| ARNOLD CRAIG | director | 2026-04-27 | A-Award | 0 | 2026-04-29 |
| ARNOLD CRAIG | director | 2026-04-28 | F-InKind | 81.9 | 2026-04-29 |
| Pieton Thierry | officer: EVP & Chief Financial Officer | 2026-03-03 | F-InKind | 96.71 | 2026-03-05 |
| KIIL HARRY SKIP | officer: EVP & President Cardiovascular | 2026-02-19 | M-Exempt | 80 | 2026-02-26 |
| KIIL HARRY SKIP | officer: EVP & President Cardiovascular | 2026-02-19 | M-Exempt | 87.76 | 2026-02-26 |
| KIIL HARRY SKIP | officer: EVP & President Cardiovascular | 2026-02-19 | S-Sale | 97.86 | 2026-02-26 |
| KIIL HARRY SKIP | officer: EVP & President Cardiovascular | 2026-02-19 | M-Exempt | 93.08 | 2026-02-26 |
| KIIL HARRY SKIP | officer: EVP & President Cardiovascular | 2026-02-19 | S-Sale | 97.6634 | 2026-02-26 |
| KIIL HARRY SKIP | officer: EVP & President Cardiovascular | 2026-02-19 | S-Sale | 97.77 | 2026-02-26 |
| KIIL HARRY SKIP | officer: EVP & President Cardiovascular | 2026-02-19 | S-Sale | 97.825 | 2026-02-26 |
| KIIL HARRY SKIP | officer: EVP & President Cardiovascular | 2026-02-19 | S-Sale | 97.82 | 2026-02-26 |
| KIIL HARRY SKIP | officer: EVP & President Cardiovascular | 2026-02-19 | M-Exempt | 87.76 | 2026-02-26 |
| KIIL HARRY SKIP | officer: EVP & President Cardiovascular | 2026-02-19 | M-Exempt | 93.08 | 2026-02-26 |
| KIIL HARRY SKIP | officer: EVP & President Cardiovascular | 2026-02-19 | M-Exempt | 80 | 2026-02-26 |
| Blomquist Denise L. | officer: Chief Accounting Officer | 2026-02-20 | G-Gift | 0 | 2026-02-24 |
| Blomquist Denise L. | officer: Chief Accounting Officer | 2026-01-29 | F-InKind | 101 | 2026-02-02 |
| Wall Brett A. | officer: EVP & Pres Neuroscience | 2025-12-15 | F-InKind | 99.87 | 2025-12-17 |
| Marinaro Michael | officer: EVP, Pres MedSurg and Americas | 2025-12-15 | F-InKind | 99.87 | 2025-12-17 |
| Martha Geoffrey | director, officer: Chairman and CEO | 2025-12-15 | F-InKind | 99.87 | 2025-12-17 |
| KIIL HARRY SKIP | officer: EVP & President Cardiovascular | 2025-12-05 | F-InKind | 101.36 | 2025-12-09 |
| Blomquist Denise L. | officer: Chief Accounting Officer | 2025-11-20 | G-Gift | 0 | 2025-11-24 |
| Smith Gregory L | officer: EVP Global Ops & Supply Chain | 2025-11-19 | S-Sale | 101.93 | 2025-11-21 |
| Smith Gregory L | officer: EVP Global Ops & Supply Chain | 2025-11-19 | S-Sale | 101.99 | 2025-11-21 |
| Smith Gregory L | officer: EVP Global Ops & Supply Chain | 2025-11-19 | S-Sale | 102.03 | 2025-11-21 |
| Smith Gregory L | officer: EVP Global Ops & Supply Chain | 2025-11-19 | S-Sale | 102.04 | 2025-11-21 |
| Smith Gregory L | officer: EVP Global Ops & Supply Chain | 2025-11-19 | S-Sale | 102.05 | 2025-11-21 |
| Smith Gregory L | officer: EVP Global Ops & Supply Chain | 2025-11-19 | S-Sale | 102.06 | 2025-11-21 |
| Smith Gregory L | officer: EVP Global Ops & Supply Chain | 2025-11-19 | S-Sale | 102.08 | 2025-11-21 |
| KIIL HARRY SKIP | officer: EVP & President Cardiovascular | 2025-09-03 | S-Sale | 91.58 | 2025-09-05 |
| KIIL HARRY SKIP | officer: EVP & President Cardiovascular | 2025-09-03 | S-Sale | 91.59 | 2025-09-05 |
| Jellison William R | director | 2025-08-25 | P-Purchase | 92.37 | 2025-08-25 |
| Jellison William R | director | 2025-08-22 | P-Purchase | 92.73 | 2025-08-25 |
| Marinaro Michael | officer: EVP, Pres MedSurg and Americas | 2025-08-20 | F-InKind | 93.22 | 2025-08-21 |
| Jellison William R | director | 2025-08-19 | 0 | 2025-08-19 | |
| Groetelaars John P | director | 2025-08-19 | 0 | 2025-08-19 | |
| Walter Matthew R. | officer: SVP, Chief HR Officer | 2025-08-01 | M-Exempt | 0 | 2025-08-04 |
| Walter Matthew R. | officer: SVP, Chief HR Officer | 2025-08-01 | M-Exempt | 78 | 2025-08-04 |
| Walter Matthew R. | officer: SVP, Chief HR Officer | 2025-08-01 | F-InKind | 89.34 | 2025-08-04 |
| Walter Matthew R. | officer: SVP, Chief HR Officer | 2025-08-01 | F-InKind | 89.34 | 2025-08-04 |
| Walter Matthew R. | officer: SVP, Chief HR Officer | 2025-08-01 | F-InKind | 89.34 | 2025-08-04 |
| Walter Matthew R. | officer: SVP, Chief HR Officer | 2025-08-01 | M-Exempt | 78 | 2025-08-04 |
| Walter Matthew R. | officer: SVP, Chief HR Officer | 2025-08-01 | M-Exempt | 0 | 2025-08-04 |
| Wall Brett A. | officer: EVP & Pres Neuroscience | 2025-08-01 | M-Exempt | 0 | 2025-08-04 |
| Wall Brett A. | officer: EVP & Pres Neuroscience | 2025-08-01 | F-InKind | 89.34 | 2025-08-04 |
| Wall Brett A. | officer: EVP & Pres Neuroscience | 2025-08-01 | F-InKind | 89.34 | 2025-08-04 |
| Wall Brett A. | officer: EVP & Pres Neuroscience | 2025-08-01 | M-Exempt | 0 | 2025-08-04 |